A Vancouver agri-tech company wants to give canola growers another weapon in the never-ending battle against flea beetles.

RNA interference – RNAi – functions specifically to silence, or deactivate, genes. Among other applications, it promises to be groundbreaking as a way to treat infections of bees by a commercially ...

That’s now happening. Researchers have uncovered genes that play a role in a number of chronic conditions. And they have invented new types of therapies to target their genetic roots. One of the most ...

Report covers Silexion Therapeutics (NASDAQ: SLXN), a disruptive player in the precision oncology space, developing innovative RNAi therapies targeting KRAS-driven cancers, highlighting the company’s ...

New solutions to previously uncontrolled pests, improved application efficicacy and climate resilience are all benefits Ryan Rapp, CEO and co-founder of Terrana Biosciences, says are possible. The ...

LONDON--(BUSINESS WIRE)--Silexion Therapeutics (NASDAQ: SLXN) has emerged an intriguing yet under the radar player in the precision oncology space, focusing on developing innovative RNA interference ...